1. Home
  2. JMM vs LSB Comparison

JMM vs LSB Comparison

Compare JMM & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JMM
  • LSB
  • Stock Information
  • Founded
  • JMM 1988
  • LSB 2002
  • Country
  • JMM United States
  • LSB China
  • Employees
  • JMM N/A
  • LSB N/A
  • Industry
  • JMM Trusts Except Educational Religious and Charitable
  • LSB
  • Sector
  • JMM Finance
  • LSB
  • Exchange
  • JMM Nasdaq
  • LSB NYSE
  • Market Cap
  • JMM 57.7M
  • LSB 49.8M
  • IPO Year
  • JMM N/A
  • LSB N/A
  • Fundamental
  • Price
  • JMM $6.00
  • LSB $2.51
  • Analyst Decision
  • JMM
  • LSB
  • Analyst Count
  • JMM 0
  • LSB 0
  • Target Price
  • JMM N/A
  • LSB N/A
  • AVG Volume (30 Days)
  • JMM 16.1K
  • LSB 15.7K
  • Earning Date
  • JMM 01-01-0001
  • LSB 01-21-2025
  • Dividend Yield
  • JMM 5.44%
  • LSB N/A
  • EPS Growth
  • JMM N/A
  • LSB N/A
  • EPS
  • JMM N/A
  • LSB N/A
  • Revenue
  • JMM N/A
  • LSB $79,415,311.00
  • Revenue This Year
  • JMM N/A
  • LSB $39.33
  • Revenue Next Year
  • JMM N/A
  • LSB $75.61
  • P/E Ratio
  • JMM N/A
  • LSB N/A
  • Revenue Growth
  • JMM N/A
  • LSB N/A
  • 52 Week Low
  • JMM $5.29
  • LSB $1.88
  • 52 Week High
  • JMM $6.10
  • LSB $11.20
  • Technical
  • Relative Strength Index (RSI)
  • JMM 40.73
  • LSB 44.96
  • Support Level
  • JMM $6.03
  • LSB $2.10
  • Resistance Level
  • JMM $6.16
  • LSB $2.77
  • Average True Range (ATR)
  • JMM 0.04
  • LSB 0.36
  • MACD
  • JMM -0.00
  • LSB 0.01
  • Stochastic Oscillator
  • JMM 5.88
  • LSB 34.68

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: